ArticleProstate cancer and prostatic diseases2021

Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.

Naomi B Haas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.